Mt-lab – Scouting, investing

Innovative technology platforms based on plant-derived extracellular vesicles for vaccines and wound care therapies

Development of a novel treatment for small abdominal aortic aneurysms

A biopharmaceutical company focused on the next generation of antibody therapeutics

A clinical-stage drug company developing a high-dose statin for early intervention in a blinding eye disease.

A Digital Health company focused on eye tracking based digital biomarkers

Mt-lab is an operational industrial holding that invests in companies developing disruptive healthcare products, services and technologies.

MT-LAB TEAM

A cumulative 160+ years of experience in the healthcare industry…

SEE OUR COMPANIES

Young, very agile and highly innovative companies burning up with ideas…

LATEST NEWS

SOMAREALITY

Somareality: Vienna-based DeepTech Startup Receives €1.5 Million Investment

23 May 2024

Somareality was founded in Vienna in 2019 and develops eye-tracking-based biomarkers to infer a person’s cognitive state. With the first biomarker, they achieved nearly one million in revenue, and by 2026, they aim to introduce more biomarkers, collectively enabling comprehensive non-invasive cognitive monitoring. Somareality with a Pivot The current million-dollar investment, supported by local investors […]

EPOK Therapeutics

EPOK Therapeutics announced today the completion of a $9.0m Seed Round financing

23 March 2023

EPOK Therapeutics Inc. (“EPOK” or the “Company”), a preclinical stage biotech company developing diabodies and antibody conjugates, announced today the completion of a $9.0m Seed Round financing, led by Canadian and Italian angel investors. The proceeds from the financing will support the preclinical development of two proprietary drug candidates. In conjunction with the financing, the […]